| Literature DB >> 19781074 |
Isabelle Kaelin-Gambirasio1, Sandrine Jacob, Michel Boulvain, Jean-Bernard Dubuisson, Patrick Dällenbach.
Abstract
BACKGROUND: The transobturator tape procedure (TOT) is an effective surgical treatment of female stress urinary incontinence. However data concerning safety are rare, follow-up is often less than two years, and complications are probably underreported. The aim of this study was to describe early and late complications associated with TOT procedures and identify risk factors for erosions.Entities:
Mesh:
Year: 2009 PMID: 19781074 PMCID: PMC2760512 DOI: 10.1186/1472-6874-9-28
Source DB: PubMed Journal: BMC Womens Health ISSN: 1472-6874 Impact factor: 2.809
Characteristics of the study population
| Age (y) mean (SD) | 57.9 (13.2) |
| Height (cm) mean (SD) | 1.60 (0.06) |
| Weight (kg) mean (SD) | 70.7 (14) |
| BMI (kg/m2) mean (SD) | 27.6 (5) |
| Menopause n (%) | 156 (67) |
| HT n (%) | 52 (22.3) |
| Menopause without HT n (%) | 104 (44.6) |
| Pure stress incontinence n (%) | 153 (65.7) |
| Mixed urinary incontinence n (%) | 80 (34.3) |
| Previous hysterectomy n (%) | 40 (17.2) |
| Previous prolapse surgery n (%) | 31 (13.3) |
| Sexual Activity n (%) | 156 (67) |
BMI = body mass index; HT = hormonal replacement therapy
Complications
| During procedure n (%) | |||||
| Haemorrhage>200 ml | 12 (5.2) | 2 (2.6) | 9 (8.9) | 1 (1.8) | 0.07 |
| Vaginal perforation | 2(0.9) | 0 | 2 (2.0) | 0 | 0.27 |
| Bladder perforation | 0 (0) | 0 | 0 | 0 | NA |
| Early-postoperative n (%) | |||||
| Urinary retention | 6 (2.6%) | 3 (3.9) | 1 (1.0) | 2 (3.6) | 0.41 |
| Section of the sling | 1(0.4%) | 0 | 0 | 1 (1.8) | 0.21 |
| Haematoma | 1(0.4%) | 0 | 0 | 1 (1.8) | 0.21 |
| Late post-operative* n (%) | |||||
| Vaginal erosions | 17 (7.6%) | 13 (17.8) | 4 (4.0) | 0 | >0.001 |
| Reintervention† | 14 (6.2%) | 11 (15.1) | 3 (3.0) | 0 | 0.001 |
| Abscess | 1 (0.4%) | 1 (1.4) | 0 | 0 | 0.35 |
| | 14 (6.2%) | 7 (9.6) | 5 (5.1) | 2 (3.8) | 0.33 |
| | 14 (6.2%) | 8 (11.0) | 2 (2.0) | 4 (7.5) | 0.05 |
| Perineal pain | 5 (2.2%) | 2 (2.7) | 2 (2.0) | 1 (1.9) | 0.93 |
| Worsening of urgency | 9 (4.0%) | 3 (4.1) | 3 (3.0) | 3 (5.7) | 0.73 |
P values are calculated with the chi-squared test
*Percentage are calculated with N = 225 (73 Obtape®, 99 Aris®, 53 TVT-O®)
†Reinterventionfor vaginal erosion
Figure 1Survival analysis comparing Aris.
Comparisons between women with and without erosions (N = 225)
| Type of sling n (%) | ||||
| Obtape® | 13 (76.5) | 60 (28.8) | Réf. | |
| Aris® | 4 (23.5) | 95 (45.7) | 0.23 (0.08-0.67) | 0.003 |
| TVT-O® | 0 | 53 (25.5) | NA | 0.001 |
| Haemorrhage > 200 ml n (%) | 2 (5.9) | 10 (4.8) | 2.37 (0.61-9.18) | 0.22 |
| Sexual activity n (%) | ||||
| No | 4 (23.5%) | 65 (31.3%) | Réf. | |
| Yes | 13 (76.5%) | 143 (68.8%) | 1.44 (0.49-4.25) | 0.51 |
| Age: mean (SD) | 58.0 (13.4) | 56.9 (12.3) | NA | 0.35 |
| BMI: mean (SD) | 27.6 (1.2) | 27.7 (0.4) | NA | 0.39 |
| Concomitant surgery n (%) | ||||
| None | 9 (52.9) | 116 (55.8) | Réf. | |
| Prolapse surgery | 3 (17.6%) | 72 (34.6%) | 0.56 (0.16-1.99) | 0.36 |
| Hysterectomy | 1(5.9) | 41 (19.7%) | 0.33 (0.04-2.53) | 0.26 |
| Any surgery | 8 (47.1) | 92 (44.2) | 1.11 (0.44-2.78) | 0.82 |
| Hypoestrogeny n (%) | ||||
| No | 12 (70.6%) | 111 (53.4%) | Réf. | |
| Yes | 5 (29.4%) | 97 (46.6%) | 0.88 (0.26-2.95) | 0.84 |
P values are calculated with the chi-squared test for proportions and with the T-test for means unless specified.